PL EN
REVIEW PAPER
Interpretative intricacies of ABCA4 variants in a patient with infantile nystagmus and a diagnosis of achromatopsia type 2
Anna Futyma 1, A,C-D,F
,
 
Maciej Krawczyński 2,3, A-C,E-F
 
 
 
More details
Hide details
1
Student Scientific Society, Poznan University of Medical Sciences, Poznan, Poland
 
2
Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland
 
3
Diagnostyka GENESIS, Poznan, Poland
 
 
A - Research concept and design; B - Collection and/or assembly of data; C - Data analysis and interpretation; D - Writing the article; E - Critical revision of the article; F - Final approval of article
 
 
Submission date: 2026-04-07
 
 
Acceptance date: 2026-04-21
 
 
Publication date: 2026-10-22
 
 
Corresponding author
Anna Futyma   

Student Scientific Society, Poznan University of Medical Sciences, Polska
 
 
Ophthalmology 2026;29(3):10-12
 
KEYWORDS
TOPICS
ABSTRACT
Introduction: Infantile nystagmus is an eye movement disorder appearing before the age of 6 months. It can be of various etiologies; however, in this age group, ophthalmic disorders predominate over neurologic ones. The major cause is albinism, followed by inherited retinal dystrophies. Nonetheless, both are umbrella terms comprising numerous diseases caused by mutations in distinct genes, of different inheritance patterns and visual outcomes, necessitating a broad genetic screening. Case report: The patient was a 4-month-old boy with infantile nystagmus and suspected of ocular albinism or early-onset retinal dystrophy. Whole-exome sequencing identified four variants in retinal dystrophy genes, two pathogenic CNGA3 mutations, corroborating the diagnosis of achromatopsia, and two concomitant ABCA4 variants, a mild and a frequent hypomorphic allele. Based on the existing genotype-phenotype correlations and considering the visual limitations associated with a primary diagnosis, the detected ABCA4 variants were assumed unlikely to be significant for the patient’s visual functioning. Conclusions: The present case highlights the need for judicious evaluation of multiple variants detected via high-throughput genetic testing methods and cautions against hasty diagnoses. The mere identification of a biallelic mutation in a recessive disease-associated gene is not always sufficient to make a diagnosis, as in this instance, a diagnosis of Stargardt disease was not justified, given the mild character of the variants. Moreover, even a postulated association with age-related macular degeneration or late-onset macular dystrophic changes, considering the achromatopsia phenotype, appears to be of limited relevance for the patient, thereby underscoring the necessity of an individualized approach to each case.
REFERENCES (15)
1.
Goldman E, Hendler K, Yahalom C: Nystagmus in infancy: causes, characteristics and main tools for diagnosis. Eye (Lond). 2025; 39(5): 958–962. doi:10.1038/s41433-024-03504-4.
 
2.
Gong X, Hertle RW: Infantile Nystagmus Syndrome—Associated Inherited Retinal Diseases: Perspectives from Gene Therapy Clinical Trials. Life (Basel). 2024; 14(11): 1356. doi:10.3390/life14111356.
 
3.
Wong WM, Mahroo OA: Monogenic Retinal Diseases Associated With Genes Encoding Phototransduction Proteins: A Review. Clin Exp Ophthalmol. 2025; 53(3): 260–280. doi:10.1111/ceo.14511.
 
4.
Liu S, Li S, Wang Y, et al.: Genetic Landscape and Clinical Characterization of FRMD7-Related Infantile Nystagmus Based on Large In-House Datasets and Literature Review. Invest Ophthalmol Vis Sci. 2026; 67(1): 30. doi:10.1167/iovs.67.1.30.
 
5.
Hirji N, Aboshiha J, Georgiou M, et al.: Achromatopsia: clinical features, molecular genetics, animal models and therapeutic options. Ophthalmic Genet. 2018; 39(2): 149–57. doi:10.1080/13816810.2017.1418389.
 
6.
Michalakis S, Gerhardt M, Rudolph G, et al.: Achromatopsia: Genetics and Gene Therapy. Mol Diagn Ther. 2022; 26(1): 51–59. doi:10.1007/s40291-021-00565-z.
 
7.
Solaki M, Baumann B, Reuter P, et al.: Comprehensive variant spectrum of the CNGA3 gene in patients affected by achromatopsia. Hum Mutat. 2022; 43(7): 832–858. doi:10.1002/humu.24371.
 
8.
Lee W, Zernant J, Su PY, et al.: A genotype-phenotype correlation matrix for ABCA4 disease based on long-term prognostic outcomes. JCI Insight. 2022; 7(2): e156154. doi:10.1172/jci.insight.156154.
 
9.
Li CHZ, Pas JAAH, Corradi Z, et al.: Study of Late-Onset Stargardt Type 1 Disease: Characteristics, Genetics, and Progression. Ophthalmology. 2024; 131(1): 87–97. doi:10.1016/j.ophtha.2023.08.011.
 
10.
Runhart EH, Sangermano R, Cornelis SS, et al.: The Common ABCA4 Variant p.Asn1868Ile Shows Nonpenetrance and Variable Expression of Stargardt Disease When Present in trans With Severe Variants. Invest Ophthalmol Vis Sci. 2018; 59(8): 3220–3231. doi:10.1167/iovs.18-23881.
 
11.
Westeneng-van Haaften SC, Boon CJF, Cremers FPM, et al.: Clinical and genetic characteristics of late-onset Stargardt’s disease. Ophthalmology. 2012; 119(6): 1199–1210. doi:10.1016/j.ophtha.2012.01.005.
 
12.
Allikmets R: Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet. 2000; 67(2): 487–491. doi:10.1086/303018.
 
13.
Shroyer NF, Lewis RA, Yatsenko AN, et al.: Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration. Hum Mol Genet. 2001; 10(23): 2671–2678. doi:10.1093/hmg/10.23.2671.
 
14.
Müller PL, Gliem M, Mangold E, et al.: Monoallelic ABCA4 Mutations Appear Insufficient to Cause Retinopathy: A Quantitative Autofluorescence Study. Invest Ophthalmol Vis Sci. 2015; 56(13): 8179–8186. doi:10.1167/iovs.15-17629.
 
15.
Kjellström U, Andréasson S. A: five-year follow-up of ABCA4 carriers showing deterioration of retinal function and increased structural changes. Mol Vis. 2022; 28: 300–316.
 
eISSN:1689-362X
ISSN:1505-2753
Journals System - logo
Scroll to top